Trial for keeping weight off after stopping GLP-1 meds
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests if other medicines (naltrexone, metformin, or rapamycin) can help people keep off weight they lost while taking GLP-1 drugs like Wegovy or Ozempic, after they stop taking them. It is for AgelessRx patients aged 40 to 85 who have lost at least 15 pounds on GLP-1s.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an existing patient of AgelessRx.
- You are between 40 and 85 years old.
- Your BMI is 22 or higher.
- You have been taking GLP-1 drugs (Wegovy, Ozempic, or compounded forms) for at least three months.
- You have lost at least 15 pounds while using GLP-1 drugs.
- You do not have a history of weight-loss surgery or have not used other weight-loss drugs in the past six months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a 6-month behavioral program (including exercise, diet, and mindfulness) designed to help you keep weight off after stopping GLP-1 or similar weight-loss medications. It's for people who have already lost at least 15% of their body weight and stopped or are stopping these medications.
This study looks at how a medical weight loss program affects biological aging using a simple blood test. It is for adults who are overweight or have obesity and may help show if weight loss can slow aging.
This trial tests whether a very low ('micro') dose of semaglutide can improve health, quality of life, and how long you live well. It's for people who are interested in the drug's general health benefits but not specifically for weight loss.
This trial tests whether a probiotic supplement called UltraFlora Triplebiotic can help prevent weight gain after stopping a GLP-1 medication. If you recently stopped a GLP-1 drug, this study may help you maintain your weight.
This study tests whether a newer class of weight-loss medicines (GLP-1 and GIP/GLP-1 analogues) can help people with excess body weight eat healthier and improve their metabolism and behavior. It may be a good option if you are an adult with overweight or obesity and haven't used these medicines recently.
This study follows people who recently stopped taking a GLP-1 medication (like Wegovy or Ozempic) to understand how weight, eating habits, and daily routines change over time. It aims to help patients and doctors know what to expect after stopping the drug.
Hear when a new Longevity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.